Velthorst E, Froudist-Walsh S, Stahl E, et al. Genetic risk for schizophrenia and autism, social impairment and developmental pathways to psychosis. Transl Psychiatry. 2018;8(1):204. doi:10.1038/s41398-018-0229-0
International Consortium on Lithium Genetics (ConLi+Gen), Amare AT, Schubert KO, et al. Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study. JAMA Psychiatry. 2018;75(1):65-74. doi:10.1001/jamapsychiatry.2017.3433
Shafee R, Nanda P, Padmanabhan JL, et al. Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Transl Psychiatry. 2018;8(1):78. doi:10.1038/s41398-018-0124-8
Ruderfer DM, Fanous AH, Ripke S, et al. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol Psychiatry. 2014;19(9):1017-24. doi:10.1038/mp.2013.138
Xu Q, Wu X, Li M, et al. Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population. Pharmacogenomics J. 2016;16(4):357-65. doi:10.1038/tpj.2015.61
Mohnke S, Erk S, Schnell K, et al. Theory of mind network activity is altered in subjects with familial liability for schizophrenia. Soc Cogn Affect Neurosci. 2016;11(2):299-307. doi:10.1093/scan/nsv111
Hill K, Buchholz A, Amsbaugh H, et al. Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment. Schizophr Res. 2015;166(1-3):310-5. doi:10.1016/j.schres.2015.05.018